ERBB2 and neoplasm: HER2 overexpression was less frequent in patients with peritoneal metastases (127 (7%) vs 280 (13%), p < 0.001), whereas tumours in patients with peritoneal metastases were more likely to be a signet-ring cell gastric carcinoma (237 (13%) vs 115 (5%), p < 0.001).